press_release_conclusion: Scientists at the University of Liverpool have discovered that treating the immune system of patients with Complex Regional Pain Syndrome (CPRS) leads to a significant reduction in pain.
abstract_conclusion: IVIG, 0.5 g/kg, can reduce pain in refractory CRPS.